Fosamax and Valcyte drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fosamax and Valcyte. Common interactions include sinusitis among females and nausea among males.

The phase IV clinical study analyzes what interactions people who take Fosamax and Valcyte have. It is created by eHealthMe based on reports of 75 people who take Fosamax and Valcyte from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Apr, 01, 2023

75 people who take Fosamax and Valcyte together, and have interactions are studied.


What is Fosamax?

Fosamax has active ingredients of alendronate sodium. It is often used in osteoporosis. eHealthMe is studying from 99,637 Fosamax users for its effectiveness, alternative drugs and more.

What is Valcyte?

Valcyte has active ingredients of valganciclovir hydrochloride. It is often used in cmv - immunocompromised host. eHealthMe is studying from 5,946 Valcyte users for its effectiveness, alternative drugs and more.

Number of Fosamax and Valcyte reports submitted per year:

Fosamax and Valcyte drug interactions.

Common Fosamax and Valcyte drug interactions by gender *:

female:

  1. Sinusitis
  2. Renal failure
  3. Erythema
  4. Gait disturbance
  5. Joint range of motion decreased
  6. Musculoskeletal stiffness
  7. Pruritus generalised
  8. Skin discolouration
  9. Skin exfoliation
  10. Skin hyperpigmentation

male:

  1. Nausea
  2. Diarrhoea
  3. Complications of transplanted kidney
  4. Decreased appetite
  5. Respiratory syncytial virus infection
  6. Asthenia
  7. Encephalopathy
  8. Fatigue
  9. Hypokalaemia
  10. Insomnia

Common Fosamax and Valcyte drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Complications of transplanted kidney
  2. Diarrhoea
  3. Haemolytic uraemic syndrome
  4. Hiatus hernia
  5. Hyperkalaemia
  6. Hypokalaemia
  7. Intra-abdominal haematoma
  8. Kidney fibrosis
  9. Lymphocele
  10. Renal tubular atrophy

30-39:

  1. Blood cholesterol increased
  2. Abdominal pain upper
  3. Alcohol use
  4. Arrhythmia
  5. Blood thyroid stimulating hormone increased
  6. Cardiac failure congestive
  7. Cardiomegaly
  8. Contusion
  9. Cytomegalovirus test positive
  10. Deafness unilateral

40-49:

  1. Blood amylase increased
  2. Cytomegalovirus antibody positive
  3. Leukopenia
  4. Myalgia
  5. Neutropenia
  6. Orthostatic hypotension
  7. Pain
  8. Pancreas transplant rejection
  9. Pathogen resistance
  10. Staphylococcal infection

50-59:

  1. Musculoskeletal stiffness
  2. Nephrogenic systemic fibrosis
  3. Pain
  4. Pruritus generalised
  5. Skin discolouration
  6. Skin exfoliation
  7. Skin hyperpigmentation
  8. Skin hypertrophy
  9. Skin induration
  10. Skin tightness

60+:

  1. Nausea
  2. Blood creatinine increased
  3. Insomnia
  4. Pancreatitis
  5. Renal tubular necrosis
  6. Vomiting
  7. Renal failure
  8. Arrhythmia
  9. Blood thyroid stimulating hormone increased
  10. Clostridium difficile colitis

Common conditions people have *:

  1. Pain: 9 people, 12.00%
  2. High Blood Pressure: 6 people, 8.00%
  3. Constipation: 6 people, 8.00%
  4. Immunodeficiency Disorders: 5 people, 6.67%
  5. Idiopathic Pulmonary Fibrosis (chronic lung disease): 4 people, 5.33%
  6. High Blood Cholesterol: 4 people, 5.33%
  7. Diabetes: 4 people, 5.33%
  8. Cytomegalovirus Viraemia (cytomegalo virus in blood stream): 4 people, 5.33%

* Approximation only. Some reports may have incomplete information.

Do you take Fosamax and Valcyte?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Fosamax and Valcyte interactions:

Browse all drug interactions of Fosamax and Valcyte:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Fosamax side effects:

Browse all side effects of Fosamax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Valcyte side effects:

Browse all side effects of Valcyte:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Fosamax interactions:

Browse all interactions between Fosamax and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Valcyte interactions:

Browse all interactions between Valcyte and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on alendronate sodium and valganciclovir hydrochloride (the active ingredients of Fosamax and Valcyte, respectively), and Fosamax and Valcyte (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Fosamax and Valcyte.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: